ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in San Diego, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Ovarian Cancer
Breast Cancer
Ovarian Epithelial Carcinoma
Triple Negative Breast Cancer
Adenocarcinoma

Endometrial Cancer trials near San Diego, CA, USA:

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer (DUO-E)

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Drug: Carboplatin
Biological: durvalumab

Phase 3

AstraZeneca
AstraZeneca

La Jolla, California, United States and 202 other locations

This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in...

Enrolling
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Endometrial Cancer
Biological: vudalimab

Phase 2

Xencor
Xencor

La Jolla, California, United States of America and 11 other locations

in participants with solid tumors.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be remov...

Enrolling
Endometrial Cancer
Non-small Cell Lung Cancer
Drug: PRO1184 intravenous infusion of PRO1184
Drug: PRO1184

Phase 1, Phase 2

ProfoundBio

San Diego, California, United States and 21 other locations

in participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSigna...

Enrolling
Endometrial Adenocarcinoma
Platinum-resistant Ovarian Cancer
Drug: ACR-368
Diagnostic Test: OncoSignature

Phase 1, Phase 2

Acrivon Therapeutics

La Jolla, California, United States and 67 other locations

The purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors an...

Active, not recruiting
Esophageal Cancer
Urologic Cancer
Drug: Niraparib

Phase 2

Tempus AI
Tempus AI

San Diego, California, United States of America and 79 other locations

TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...

Enrolling
Endometrial Cancer
Gastric Cancer
Drug: Carboplatin
Drug: Leucovorin LV

Phase 2

AstraZeneca
AstraZeneca

San Diego, California, United States and 92 other locations

-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Lower Esophageal Cancer
Drug: cabozantinib
Drug: atezolizumab

Phase 1, Phase 2

Exelixis
Exelixis

La Jolla, California, United States and 123 other locations

The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...

Active, not recruiting
Endometrial Neoplasms
Drug: Placebo for pembrolizumab
Drug: Cisplatin (as radiosensitizer)

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

La Jolla, California, United States and 230 other locations

The primary objective of this study is to assess the safety and tolerability and to determine the recommended Phase 2 dose (RP2D) of E7386 in combina...

Enrolling
Endometrial Neoplasms
Carcinoma, Hepatocellular
Drug: Lenvatinib
Drug: E7386

Phase 1

Eisai
Eisai

La Jolla, California, United States and 47 other locations

consist of Part 1 which includes 7 cohorts of: urothelial bladder cancer, biliary tract cancer, cervical cancer, endometrial...

Enrolling
Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer
Drug: Trastuzumab deruxtecan

Phase 2

AstraZeneca
AstraZeneca

La Jolla, California, United States and 116 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems